215 related articles for article (PubMed ID: 11021533)
21. Structure/function relationship of activating Ly-49D and inhibitory Ly-49G2 NK receptors.
Ortaldo JR; Winkler-Pickett R; Willette-Brown J; Wange RL; Anderson SK; Palumbo GJ; Mason LH; McVicar DW
J Immunol; 1999 Nov; 163(10):5269-77. PubMed ID: 10553049
[TBL] [Abstract][Full Text] [Related]
22. Allelic variation in the ectodomain of the inhibitory Ly-49G2 receptor alters its specificity for allogeneic and xenogeneic ligands.
Silver ET; Lavender KJ; Gong DE; Hazes B; Kane KP
J Immunol; 2002 Nov; 169(9):4752-60. PubMed ID: 12391184
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a novel killer cell lectin-like receptor (KLRH1) expressed by alloreactive rat NK cells.
Naper C; Hayashi S; Løvik G; Kveberg L; Niemi EC; Rolstad B; Dissen E; Ryan JC; Vaage JT
J Immunol; 2002 May; 168(10):5147-54. PubMed ID: 11994469
[TBL] [Abstract][Full Text] [Related]
24. Contrasting roles of DAP10 and KARAP/DAP12 signaling adaptors in activation of the RBL-2H3 leukemic mast cell line.
Anfossi N; Lucas M; Diefenbach A; Bühring HJ; Raulet D; Tomasello E; Vivier E
Eur J Immunol; 2003 Dec; 33(12):3514-22. PubMed ID: 14635062
[TBL] [Abstract][Full Text] [Related]
25. Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells.
Bakker AB; Baker E; Sutherland GR; Phillips JH; Lanier LL
Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9792-6. PubMed ID: 10449773
[TBL] [Abstract][Full Text] [Related]
26. DAP12-based activating chimeric antigen receptor for NK cell tumor immunotherapy.
Töpfer K; Cartellieri M; Michen S; Wiedemuth R; Müller N; Lindemann D; Bachmann M; Füssel M; Schackert G; Temme A
J Immunol; 2015 Apr; 194(7):3201-12. PubMed ID: 25740942
[TBL] [Abstract][Full Text] [Related]
27. A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors.
Lowin-Kropf B; Kunz B; Schneider P; Held W
Eur J Immunol; 2002 Mar; 32(3):773-82. PubMed ID: 11870621
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the linker for activation of T cells and the linker for activation of B cells in natural killer cells reveals a novel signaling cassette, dual usage in ITAM signaling, and influence on development of the Ly49 repertoire.
Whittaker GC; Burshtyn DN; Orr SJ; Quigley L; Hodge DL; Pascal V; Zhang W; McVicar DW
Blood; 2008 Oct; 112(7):2869-77. PubMed ID: 18645037
[TBL] [Abstract][Full Text] [Related]
29. Vav1 controls DAP10-mediated natural cytotoxicity by regulating actin and microtubule dynamics.
Graham DB; Cella M; Giurisato E; Fujikawa K; Miletic AV; Kloeppel T; Brim K; Takai T; Shaw AS; Colonna M; Swat W
J Immunol; 2006 Aug; 177(4):2349-55. PubMed ID: 16887996
[TBL] [Abstract][Full Text] [Related]
30. Mouse CD94 participates in Qa-1-mediated self recognition by NK cells and delivers inhibitory signals independent of Ly-49.
Toyama-Sorimachi N; Taguchi Y; Yagita H; Kitamura F; Kawasaki A; Koyasu S; Karasuyama H
J Immunol; 2001 Mar; 166(6):3771-9. PubMed ID: 11238619
[TBL] [Abstract][Full Text] [Related]
31. Positive impact of inhibitory Ly49 receptor-MHC class I interaction on NK cell development.
Lowin-Kropf B; Held W
J Immunol; 2000 Jul; 165(1):91-5. PubMed ID: 10861039
[TBL] [Abstract][Full Text] [Related]
32. DAP12: a key accessory protein for relaying signals by natural killer cell receptors.
Campbell KS; Colonna M
Int J Biochem Cell Biol; 1999 Jun; 31(6):631-6. PubMed ID: 10404635
[TBL] [Abstract][Full Text] [Related]
33. Association of DAP12 with activating CD94/NKG2C NK cell receptors.
Lanier LL; Corliss B; Wu J; Phillips JH
Immunity; 1998 Jun; 8(6):693-701. PubMed ID: 9655483
[TBL] [Abstract][Full Text] [Related]
34. Cloning and characterization of a novel activating Ly49 closely related to Ly49A.
Makrigiannis AP; Gosselin P; Mason LH; Taylor LS; McVicar DW; Ortaldo JR; Anderson SK
J Immunol; 1999 Nov; 163(9):4931-8. PubMed ID: 10528196
[TBL] [Abstract][Full Text] [Related]
35. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells.
Lanier LL; Corliss BC; Wu J; Leong C; Phillips JH
Nature; 1998 Feb; 391(6668):703-7. PubMed ID: 9490415
[TBL] [Abstract][Full Text] [Related]
36. Multiplicity and plasticity of natural killer cell signaling pathways.
Chiesa S; Mingueneau M; Fuseri N; Malissen B; Raulet DH; Malissen M; Vivier E; Tomasello E
Blood; 2006 Mar; 107(6):2364-72. PubMed ID: 16291591
[TBL] [Abstract][Full Text] [Related]
37. NKp44 triggers NK cell activation through DAP12 association that is not influenced by a putative cytoplasmic inhibitory sequence.
Campbell KS; Yusa S; Kikuchi-Maki A; Catina TL
J Immunol; 2004 Jan; 172(2):899-906. PubMed ID: 14707061
[TBL] [Abstract][Full Text] [Related]
38. Association of signal-regulatory proteins beta with KARAP/DAP-12.
Tomasello E; Cant C; Bühring HJ; Vély F; André P; Seiffert M; Ullrich A; Vivier E
Eur J Immunol; 2000 Aug; 30(8):2147-56. PubMed ID: 10940905
[TBL] [Abstract][Full Text] [Related]
39. Cumulative inhibition of NK cells and T cells resulting from engagement of multiple inhibitory Ly49 receptors.
Hanke T; Raulet DH
J Immunol; 2001 Mar; 166(5):3002-7. PubMed ID: 11207249
[TBL] [Abstract][Full Text] [Related]
40. Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages.
Nataf S; Anginot A; Vuaillat C; Malaval L; Fodil N; Chereul E; Langlois JB; Dumontel C; Cavillon G; Confavreux C; Mazzorana M; Vico L; Belin MF; Vivier E; Tomasello E; Jurdic P
Am J Pathol; 2005 Jan; 166(1):275-86. PubMed ID: 15632019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
